Gene therapy progress and prospects cancer: oncolytic viruses. - Test2 - elhamkhani - TriplyDB

Gene therapy progress and prospects cancer: oncolytic viruses.

Gene therapy progress and prospects cancer: oncolytic viruses.

http://www.wikidata.org/entity/Q34770611

about

Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer Going viral: a review of replication-selective oncolytic adenoviruses Anti-tumor activity of a miR-199-dependent oncolytic adenovirus An Ecological Framework of the Human Virome Provides Classification of Current Knowledge and Identifies Areas of Forthcoming Discovery Gene Therapy: A Paradigm Shift in Dentistry Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas Engineering of Brome mosaic virus for biomedical applications Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic Development of a selective biopharmaceutical from Herpes simplex virus type 1 glycoproteins E and I for blocking antibody mediated neutralization of oncolytic viruses.Gene Therapy and its Implications in Dentistry.Targeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice.Enhanced antitumor effects of an engineered measles virus Edmonston strain expressing the wild-type N, P, L genes on human renal cell carcinoma Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice.Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment.Indole-3-carbinol (I3C) increases apoptosis, represses growth of cancer cells, and enhances adenovirus-mediated oncolysis Development of a regulatable oncolytic herpes simplex virus type 1 recombinant virus for tumor therapy.Complete regression of human malignant mesothelioma xenografts following local injection of midkine promoter-driven oncolytic adenovirus A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models.Targeting cancer-initiating cells with oncolytic viruses.Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma.Oncolytic measles virus encoding thyroidal sodium iodide symporter for squamous cell cancer of the head and neck radiovirotherapy.Polyethyleneimine-modified calcium carbonate nanoparticles for p53 gene delivery Experimental Adaptation of Rotaviruses to Tumor Cell Lines.Effective oncolytic vaccinia therapy for human sarcomas.Systemic delivery of oncolytic adenoviruses targeting transforming growth factor-β inhibits established bone metastasis in a prostate cancer mouse model.Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.Characterization of an Oncolytic Adenovirus Vector Constructed to Target the cMet Receptor A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinoma Emerging cancer vaccines: the promise of genetic vectors.Immunotherapy for liver tumors: present status and future prospects.Oncolytic adenovirus mediated Survivin knockdown by RNA interference suppresses human colorectal carcinoma growth in vitro and in vivo Coronavirus genetically redirected to the epidermal growth factor receptor exhibits effective antitumor activity against a malignant glioblastoma Oncolytic vaccinia therapy of squamous cell carcinoma.Gene therapy in Alzheimer's disease - potential for disease modification A novel oncolytic viral therapy and imaging technique for gastric cancer using a genetically engineered vaccinia virus carrying the human sodium iodide symporter.In vitro dynamic visualization analysis of fluorescently labeled minor capsid protein IX and core protein V by simultaneous detection Hypoxia-regulated overexpression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth.Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways.Possible applications for replicating HIV 1 vectors Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool.

P2860

Q24611278-D215D714-DE52-4BB7-A7ED-E91E8379FA2D Q26797520-523F8CA2-D738-41BB-A85A-CD86CC4FB050 Q27307206-0D189DC7-9DDA-477D-95E0-29B68494883E Q27468626-F4B68FD3-82B4-44D5-AA54-B590A89A837C Q28076033-9A9A7292-F521-4B71-B573-EB500F5B76CF Q28298788-143A2FA4-B8AA-44BB-A1D3-D8283BB5D469 Q28818683-36919069-F975-479E-95F4-873ED293B1F7 Q30300019-8B79DDE1-DE22-465B-8B65-49140394766E Q30318510-BC654B9F-EDF5-48E4-B6F6-12CC42775894 Q30356405-D2405759-7E82-44A8-9464-FB7A20CE49AB Q33584637-F0509C9A-D33A-4D55-B87B-0A9A836DA181 Q33731148-D0C4B84D-38BB-47C6-82E9-F85C59A244E7 Q33815701-DC526EB5-1F6B-43D3-B1E6-C1B217E3B24F Q33824400-D05F24FF-70EB-4DAC-9DFD-54D6EFF011EC Q34028482-35A5DBEE-EED7-43DE-B116-222034639887 Q34046125-B05FDFC6-9251-4FBE-AC31-14B23266051D Q34124614-8559B985-D263-41BD-A90D-723FC271D848 Q34480521-2CD17C69-9343-499F-96F9-F927301E6A5D Q34659011-60998097-39EF-4B93-B191-F335C7EF75F4 Q35175013-BB135313-B388-4132-8967-621F54E2DB2B Q35823934-70830796-2A7A-481A-9F23-D3D6AF675A4F Q35905841-9F336730-756B-49DB-BB44-ADCF71EC766D Q35909654-21977B60-8599-4518-B5A3-92FD424DCA57 Q35954052-31E4AB7B-0FF9-45CA-8F48-A6062D739F96 Q36147503-C9976614-8320-4170-AACC-A69F9E3612B9 Q36546044-38F60904-B024-4071-8476-0365589AB126 Q36558142-87A30B0C-2CBB-410B-86DB-9A4B709915D5 Q36848730-34652AE3-030C-4FD0-A3C9-644DA09D3575 Q37137464-3E0FD465-2AB9-4993-AEB2-0B673D9EC564 Q37144014-F1073849-7CC4-47FC-A674-4FFE7B9FEAE9 Q37244951-4288E348-80CC-42CA-AF4A-8AEF67D20C1C Q37256658-CABF4FFE-17AD-4D04-B7C7-DC3A305227AE Q37270539-F7E20967-F269-4A27-9C32-DC1093C4CEEE Q37295252-D97BC14C-CC65-40E8-A221-9A8D128FCBB2 Q37444250-9EA586C6-C006-422D-A003-F2EBB259E145 Q37456186-6E6FB204-A085-4BE0-987A-F7386AD2FA8D Q37483716-D83E494F-D47C-4532-84D2-9ABD42E3CEDD Q37564490-6555015A-D1E9-4FFB-A630-4A1218E1C84D Q37768033-D4E805CD-CD4B-434F-9AB4-76A1F7C4C382 Q37780547-FA451439-2C37-4689-9D81-994A24AAAD58

P2860

Gene therapy progress and prospects cancer: oncolytic viruses.

http://www.wikidata.org/entity/Q34770611

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Gene therapy progress and prospects cancer: oncolytic viruses.

@ast

Gene therapy progress and prospects cancer: oncolytic viruses.

@en

Gene therapy progress and prospects cancer: oncolytic viruses.

@nl

type

label

Gene therapy progress and prospects cancer: oncolytic viruses.

@ast

Gene therapy progress and prospects cancer: oncolytic viruses.

@en

Gene therapy progress and prospects cancer: oncolytic viruses.

@nl

prefLabel

Gene therapy progress and prospects cancer: oncolytic viruses.

@ast

Gene therapy progress and prospects cancer: oncolytic viruses.

@en

Gene therapy progress and prospects cancer: oncolytic viruses.

@nl

P1433

Q34770611-6DE31393-F687-4E65-9A05-920EB209538F

P1476

Q34770611-FDC3C600-C28F-4A69-A9A1-261C02797A4E

P2093

Q34770611-CDAA1A8E-C22B-475F-BEC8-29760960EC37

P2860

Q34770611-07A24615-5037-4B5E-87D2-1B7E0C41462A

Q34770611-08EBDC29-4B6F-4973-884C-1E5AE3F14AD6

Q34770611-0C4A1132-D512-4F56-BB79-0DA376DC4297

Q34770611-0ED377C5-BE25-4895-9E92-DA14F8DBE150

Q34770611-10506AFD-0B2E-4541-A096-B7ADE28E27EC

Q34770611-15D063FF-4A1D-46C2-8943-A95F3D44F1AC

Q34770611-16E0C182-2719-4ACB-AFF0-D6DE7D234E6F

Q34770611-1BD43613-5A9C-4B8C-91B3-798040F7C2DD

Q34770611-1EB7A7C9-58CC-467A-BC0B-84D88D644714

Q34770611-20C7D0F7-4A29-4D8F-B78A-E1EBCF4C032E

P2888

Q34770611-845A9C5C-FF71-4326-AED6-3CC6A884D249

P304

Q34770611-8575B654-E80E-4255-871B-D1DFD2959EDC

P31

Q34770611-87A9E3FF-0AE6-47CD-A966-F4FD3DC24780

P356

Q34770611-F3D56504-7406-4EBA-A2BC-2D63BC66C7AC

P433

Q34770611-037AFC20-03F3-4F91-9A94-6285EB0A1AE6

P478

Q34770611-ADA28D7F-96A5-4E97-8679-3E8D5F923A20

P50

Q34770611-92EC12C0-01B6-48E6-9476-D62D00739766

P577

Q34770611-4218857B-6093-4453-BABB-FBD24129CE51

P5875

Q34770611-923B97E9-40E8-4F16-96EC-E0A7A6A6C324

P698

Q34770611-886DFD8C-FA19-4697-B4D3-E5E501ECFBAE

P921

Q34770611-225B8580-2A62-4FE5-B42E-3E9C3748BC4B

Q34770611-DCCC2419-B0D1-4ADB-BF10-D445039D927F

P356

P1433

P1476

Gene therapy progress and prospects cancer: oncolytic viruses

@en

P2093

D Kirn

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus

Oncolytic adenoviruses kill breast cancer initiating CD44+CD24-/low cells.

A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitization.

Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging.

Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses

Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1

Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor.

Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.

A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor.

Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers

P2888

P304

877-884

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GT.2008.72

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5435073

http://www.w3.org/2001/XMLSchema#string

P698

18418413

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus